Company Market Research Report: Eggschain, Inc.

Company Overview

• Name: Eggschain, Inc.

• Mission: Eggschain is dedicated to combining biotech and blockchain technology to advance healthcare by enabling early disease detection, preserving essential healthcare records, and empowering patients with full control over their healthcare data. The company aims to bring the healthcare and genomics industries onto the blockchain, thereby facilitating better decision-making and advancing humanity.

• Founded: Information not available

• Founder: Wei Escala

• Key People:

• Wei Escala – Founder and CEO

• Kenneth Drury, PhD, HCLD – Chief Scientific Officer

• Carolyn Thompson, MD – Medical Director

• Kathleen Tucker, PhD, HCLD, Alex Stojanoff, PhD, HCLD, Gerry Celia, PhD, HCLD, and other members serve in leadership and advisory roles.

• Headquarters: Austin, Texas

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Eggschain is known for its patented blockchain-integrated genomics and medical records tracking system, enhancing the security and transparency of biospecimen tracking.

Products

• Blockchain Biospecimen Tracking System:

• Description: Eggschain offers a cloud-based, blockchain-integrated inventory management system that secures and tracks biospecimens such as sperm, eggs, embryos, genome, stem cells, and other genetic materials.

• Key Features:

• Blockchain integration for patient-specific data security and transparency.

• Universal tracking platform offering end-to-end visibility and accuracy.

• Integration with high complexity laboratories and medical professionals for reproductive biology and endocrinology.

• Personalized data wallets for users without revealing identifiable personal data.

Recent Developments

• Recent Developments:

• Eggschain hosted an online auction offering the first public opportunity to store a sperm account on their blockchain platform.

• The company secured a patent for their blockchain technology for tracking genetic material.

• Eggschain became the first biotech healthcare company to utilize the Bitcoin mainnet through the Stacks blockchain.

• The technology has introduced a secure, immutable way for biospecimens tracking, significantly impacting the IVF and fertility industries.

• New Products Launched: No specific new products were highlighted beyond the blockchain tracking system.

• New Features: Eggschain continues to enhance their blockchain tracking system capabilities by integrating additional biospecimen types and reinforcing security measures.

• New Partnerships:

• Partnership with Yale School of Medicine and Boston IVF Fertility Clinic to document biospecimens on the blockchain.

• Joined a cohort of 25 blockchain developers supported by The Stacks Foundation.

This structured report provides insights into the current state and offerings of Eggschain, Inc., highlighting its focus on integrating blockchain technology with healthcare to improve the security and management of genetic materials in the IVF and fertility industry.